Literature DB >> 20130145

Influenza A/H1N1_09: Australia and New Zealand's winter of discontent.

Tom Kotsimbos1, Grant Waterer, Christine Jenkins, Paul M Kelly, Allen Cheng, Robert J Hancox, Mark Holmes, Richard Wood-Baker, Simon Bowler, Louis Irving, Philip Thompson.   

Abstract

Influenza A/H1N1_09 emerged in Mexico at the end of the Northern Hemisphere winter. Within weeks, the focus shifted to the Southern Hemisphere as the introduction of the novel virus coincided with the beginning of the influenza season. Intensive public health and health services planning had occurred in Australia and New Zealand as preparation for an influenza pandemic before 2009. However, this first pandemic wave was quite different to what had been expected. Key elements of the pandemic and response are outlined from the perspective of clinicians working at the frontline of patient care. In particular, they examine why past influenza pandemics and recent history are poor predictors of the current pandemic, the discordance between potential for transmission and disease severity, the broad clinical spectrum of H1N1_09 infection, clinical and health service management issues, and the relationship between health care and government policy. Finally, they address the need for the respiratory community to show leadership in times of crisis. Lessons learned in Australia and New Zealand during 2009 have important messages for similarly resourced countries in the Northern Hemisphere in the coming months as they face their own influenza season.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130145     DOI: 10.1164/rccm.200912-1878CP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

Review 1.  Update in acute lung injury and critical care 2010.

Authors:  István Vadász; Jacob I Sznajder
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

Review 2.  Risk perception and communication in sub-Saharan Africa.

Authors:  Alexander Dodoo; Bruce Hugman
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

3.  Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.

Authors:  Arwen F Altenburg; Carolien E van de Sandt; Stella E van Trierum; Heidi L M De Gruyter; Peter R W A van Run; Ron A M Fouchier; Kenny Roose; Xavier Saelens; Asisa Volz; Gerd Sutter; Rory D de Vries; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

4.  Public health communication with frontline clinicians during the first wave of the 2009 influenza pandemic.

Authors:  Catherine J Staes; Amyanne Wuthrich; Per Gesteland; Mandy A Allison; Molly Leecaster; Julie H Shakib; Marjorie E Carter; Brittany M Mallin; Susan Mottice; Robert Rolfs; Andrew T Pavia; Brent Wallace; Adi V Gundlapalli; Matthew Samore; Carrie L Byington
Journal:  J Public Health Manag Pract       Date:  2011 Jan-Feb

5.  Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant.

Authors:  David L Gordon; Dimitar Sajkov; Richard J Woodman; Yoshikazu Honda-Okubo; Manon M J Cox; Susanne Heinzel; Nikolai Petrovsky
Journal:  Vaccine       Date:  2012-06-17       Impact factor: 3.641

6.  We should not be complacent about our population-based public health response to the first influenza pandemic of the 21st century.

Authors:  Heath A Kelly; Patricia C Priest; Geoffry N Mercer; Gary K Dowse
Journal:  BMC Public Health       Date:  2011-02-03       Impact factor: 3.295

7.  The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis.

Authors:  Megan W France; Szeanna Tai; Phillip J Masel; Vanessa L Moore; Tracy L McMahon; Alexander J Ritchie; Scott C Bell
Journal:  BMC Pulm Med       Date:  2010-02-25       Impact factor: 3.317

8.  H1N1-infected Patients in ICU and Their Clinical Outcome.

Authors:  Talkad Chandrashekar Nagesh Kumar; Nanjangudu Subramanya Shivakumar; Telugu Sitaram Deepak; Rashmi Krishnappa; Melur Shivakumar Goutam; Vivek Ganigar
Journal:  N Am J Med Sci       Date:  2012-09

9.  Differential effects of pandemic (H1N1) 2009 on remote and indigenous groups, Northern Territory, Australia, 2009.

Authors:  James McCracken Trauer; Karen Louise Laurie; Joseph McDonnell; Anne Kelso; Peter Gregory Markey
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

10.  Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.

Authors:  Arwen F Altenburg; Carolien E van de Sandt; Bobby W S Li; Ronan J MacLoughlin; Ron A M Fouchier; Geert van Amerongen; Asisa Volz; Rudi W Hendriks; Rik L de Swart; Gerd Sutter; Guus F Rimmelzwaan; Rory D de Vries
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.